BIOHITECH GLOBAL, INC. BHTG Cash Flow

Biohitech global, inc. (BHTG)

CashFlow / Quarterly

Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14
Cash flows used in operating activities:
Net loss
-3,096	-2,034	-2,887	-2,261	-2,033	-1,997	-5,495	-5,220	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss:
-	-	-	-	-	-	-	-	-	-2,307	-1,878	-2,028	-1,774	-1,643	-1,718	-1,608	-1,847	-1,462	-722	-969	-1,435	-2,234	-8	-20
Adjustments to reconcile net loss to net cash used in operations:
Depreciation and amortization
378	611	609	129	113	123	115	115	103	96	97	104	125	126	112	92	90	85	90	93	-	-	-	-
Amortization of operating lease right of use assets
-	-	-	24	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Provision for bad debts
44	15	15	15	4	0	9	11	15	60	6	22	22	8	72	-10	56	0	-20	2	-	-	-	-
Share based employee compensation
358	209	233	297	351	330	77	77	-45	144	142	88	162	161	212	138	0	0	0	0	-	-	-	-
Fees paid in stock and warrants
-	-	-	-	-	-	-	-	284	353	137	380	-	-	-	-	-	-	-	-	-	-	-	-
Fees paid in stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Fees to be paid in warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Interest resulting from amortization of financing costs and discounts
188	112	111	109	178	407	623	287	222	151	47	24	21	55	0	0	-	-	-	-	-	-	-	-
Equity loss in affiliate
0	0	0	0	-230	-179	-147	-45	-5	-5	-5	0	-	-	-	-	-	-	-	-	-	-	-	-
Interest resulting from warrants valued upon conversion of host debt instruments
0	0	0	0	0	0	3,131	3,293	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warrants modification
-	-	-	-	-	-	-	-	0	0	1	0	-	-	-	-	-	-	-	-	-	-	-	-
Loss resulting from abandonment of MBT site
0	0	0	-346	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities
-1,009	2,398	-1,135	-125	548	-320	358	611	-611	188	-221	-471	255	-612	81	187	-576	-728	34	-165	-	-	-	-
Net cash used in operating activities
-1,117	-3,998	-806	-1,212	-1,657	-636	-1,749	-2,000	-936	-1,682	-1,216	-936	-	-	-	-	-	-	-	-	-	-	-	-
Cash flows used in investing activities:
Construction in-progress and purchases of equipment, fixtures and vehicles
491	455	1,369	2,794	320	2	4	1	3	2	2	1	4	0	1	1	-96	67	12	35	-	-	-	-
Decrease (increase) in prepaid expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-3	-3
Increase in accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	250	-0	0
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	143	-0	-0
Net cash used in operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,402	-1,576	-934	-612	-915	-708	-870	-1,762	-6	-16
Sale of used machinery and equipment
-	-	-	-	-	-	-	-	3	0	0	13	0	0	0	0	-	-	-	-	-	-	-	-
Investment in Entsorga West Virginia, LLC
-	-	-	-	-	-	-	-	0	0	-0	1,034	0	0	0	0	-	-	-	-	-	-	-	-
MBT facility development costs incurredv
-	-	-	13	-	-	-	92	65	64	38	36	0	0	0	0	-	-	-	-	-	-	-	-
MBT facility development costs refunded
0	0	0	66	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) investing activities
-516	1,761	-1,382	-2,742	6,419	-98	-145	-94	-904	-66	-40	-1,058	-	-	-	-	-	-	-	-	-	-	-	-
Cash flows from financing activities:
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1	-1	92	-67	67	-35	-	-	-	-
Net change in line of credit
-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-25	33	-14	96	-82	-	-	-	-
Proceeds from promissory notes
-	-	-	-	-	-	-	-	0	0	0	786	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of senior secured credit facility and common stock
0	0	0	0	0	0	0	5,000	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of line of credit facility
0	0	0	0	0	0	0	2,463	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from new line of credit facility
0	0	0	0	500	0	0	1,000	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from the sale of Series D convertible preferred stock units
0	-15	1,037	750	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from convertible notes, including warrants and beneficial conversion features
-	-	-	-	-	-	-	-	224	1,839	370	250	1,150	0	0	0	-600	600	0	0	-	-	-	-
Proceeds from series convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,000	250	-	-	-	-	-	-	-	-
Payment of financing costs
0	18	0	43	8	0	0	237	0	7	8	8	-	32	49	82	-	-	-	-	-	-	-	-
Convertible notes deferred financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	-	-	-	-
Proceeds from long-term debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	3	-1	23	-	-	-	-
Repayments of long-term debt
2	2	2	2	2	2	2	2	3	2	2	2	2	2	2	2	2	5	0	0	-	-	-	-
Proceeds from common stock issuance, net of offering costs
0	0	0	0	0	0	0	1,125	2,270	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Advance from related party, net
0	0	60	150	0	0	0	0	0	-48	706	463	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from advances
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Proceeds from convertible notes
-	-	-	-	-	-	-	-	-224	300	0	500	-	-	-	-	-	-	-	-	-	-17	5	17
Net cash provided by financing activities
-2	3,000	2,495	853	3,988	59	-319	4,421	2,267	2,081	1,066	1,989	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,476	1,670	841	688	794	796	909	1,532	5	17
Effect of exchange rate on cash
65	-4	-2	19	-8	5	43	-4	-4	-2	20	0	-14	37	19	7	-7	-0	0	0	-	-	-	-
Net change in cash (restricted and unrestricted)
-	-	-	-3,081	-	-	-	2,322	420	329	-170	-5	149	-54	91	99	-7	7	-53	52	-3	-250	-0	0
Cash paid during the year for: Interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	70	0	0
Cash paid during the year for: Income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0